Skip to content

Local application for fungal infection.

An In Vitro, In Vivo and Clinical trial Of Somaraji Taila in the management of Dadru Kushta - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/09/058146
Enrollment
30
Registered
2023-09-29
Start date
Unknown
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere Health Condition 2: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

None listed

Sponsors

Dr Prashanth
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Screening of Organisms like Trichophyton Rubrum, Trichophyton Mentagrophytes, Microsporum Gypsum, Microsporum Cannis, Epidermophytom Floccosum is done by KOH Mounting Method. 2. Patient Having Lakshana like Daha And Kandi with or without Raga, Pidaka, Udgata Mandala, Rookshata. 3. Patient who will give Written Concent. 4. Patient with Age group 18 years to 60 Years.

Exclusion criteria

Exclusion criteria: 1. Patient who have lesion with Secondary Infection. 2. Patient with Any Systemic Disorder. 3. Patient who is Pregnant and Lactating Mother.

Design outcomes

Primary

MeasureTime frame
To check the parameters and assess the symptoms using KASI Scoring •Burning sensation •Itching To assess the efficacy of Drug Somaraji TailaTimepoint: 21 Days

Secondary

MeasureTime frame
To check the parameters & assess the symptoms using KASI Scoring •Erythema •Eruptions •Elevated circular skin lesions •dryness To Check the efficacy of drug somaraji tailaTimepoint: 21 Days

Countries

India

Contacts

Public ContactDr Prashanth

Alvas Ayurveda Medical College

shettysusheel13@gmail.com9980431676

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026